Across TCGA pan-cancer cohorts, FTLP4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of FTLP4’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where FTLP4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FTLP4 is over-expressed in tumor, although a few such as LUAD show the opposite, repressed pattern.

COAD and LUAD are the cancer types where FTLP4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FTLP4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.059	.042	2	view →
LUAD	Female	All	−0.033	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: FTLP4 RNA expression & survival · all FTLP4 data types